MR

Michael Rape

Founder of Lyterian Therapeutics

San Francisco Bay Area

Overview

Work Experience

LT

Lyterian Therapeutics

  • Co-Founder

    2022 - Current

VT

Vicinitas Therapeutics

  • Member, Scientific Advisory Board

    2022

Uo

University of California, Berkeley

  • Head, Division of Molecular Therapeutics

    2022

  • Professor

    2006

TC

The Column Group

  • iPartner

    2021

MR

Monte Rosa Therapeutics

  • Member, Scientific Advisory Board

    2020

NI

Nurix, Inc.

  • Co-founder and member, Scientific Advisory Board

    2012

Education

Relevant Websites